Nov 23,2022

Lunit Partners with CARPL.ai to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels

Lunit announced that it signed a global distribution agreement with CARPL.ai, an end-to-end healthcare technology platform that enables the development, validation, and deployment of AI solutions across clinical workflows. Under the agreement, Lunit will deliver Lunit INSIGHT CXR, an AI solution for chest x-ray image analysis, and Lunit INSIGHT MMG, an AI solution for mammography analysis, through CARPL’s platform across five countries: U.S., Australia, Brazil, India, and Singapore.  Through CARPL’s interface, healthcare providers can seamlessly access Lunit’s AI solution suite for radiology, thereby improving access, affordability, and quality of medical care globally.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Mar 04,2021

Lunit Announces Partnership to Incorporate its Chest Detection Suite into Philips' Diagnostic X-ray Suite

Lunit, a leading medical AI startup, today announced its partnership with Philips. Announced during the European Congress of Radiology (ECR) virtual event (March 3-7, 2021), the collaboration will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.

 

Lunit INSIGHT CXR detects findings and provides abnormality score on a chest X-ray image

 

 

 

Lunit INSIGHT CXR chest detection suite accurately detects 10 of the most common findings in a chest X-ray. The announcement is the latest extension of Philips' AI portfolio in precision diagnosis, which leverages this collaboration to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.

 

 

"By partnering with Philips, one of the biggest medical device companies globally, our AI will be available to its significant global installed base," said Brandon Suh, CEO of Lunit. "With the start of this partnership, we look forward to further expanding our collaboration to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI."

 

 

"For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis," said Daan van Manen, General Manager for Diagnostic X-ray at Philips. "Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact. The high performance of Lunit's AI has been validated in major clinical journals to improve accuracy and efficiency in workflow. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of smart workflow features in the Philips Radiography Unified User Interface (Eleva), our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow."

 

 

Lunit's AI software, Lunit INSIGHT CXR, is designed to provide accurate and instant analysis of chest X-ray images by mapping the location of the findings and displaying the scored calculation of its actual existence. It accurately detects 10 of the most common findings in a chest X-ray, prioritizes cases with abnormality scores, thereby allows fast triage of normal cases and enables radiologists to focus on reading abnormal cases. The algorithm performs at 97-99% accuracy rate, with its performance validated in major publications such as Radiology, JAMA Network Open, etc.

 

 

Since its foundation in 2013, Lunit has been actively involved in partnerships with global major vendors and expanding its global presence in the X-ray market. Lunit INSIGHT CXR is CE marked and clinically available in Europe, Middle East, Latin America, South East Asia, Australia, and New Zealand. It is expecting its FDA clearance within 2021.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 28,2020

Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions

Lunit, a South Korean medical AI software company, announced a partnership with Emergent Connect, a leading provider of cloud-based PACS software. This partnership will bring AI solutions to Emergent Connect’s imaging cloud customer base, allowing AI to be more easily accessible to its clients. Emergent Connect manages millions of imaging records per year and helps thousands of healthcare professionals across hospitals, imaging centers and clinics provide the best patient care possible. Through this collaboration, healthcare centers using Emergent Connect software will be able to experience cutting-edge AI solutions without additional installation or configuration.

 

 

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 14,2020

Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry

Lunit, a leading medical AI startup, today announced the expansion of its collaboration with GE Healthcare. This collaboration between GE Healthcare and Lunit will help make AI algorithms more accessible to clinicians, alleviate clinical strain and streamline workflows – supporting better patient outcomes. This collaboration between GE Healthcare and Lunit is one of the first of its kind to bring commercially available AI products from a medical AI startup to an existing X-ray equipment manufacturer – making Lunit INSIGHT CXR available via Thoracic Care Suite to GE Healthcare’s thousands of global fixed, mobile, and R&F x-ray customers at point of sale. Lunit INSIGHT CXR is CE marked and is commercially available in European Economic Area and UK.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Oct 16,2023 TOP STORY

FINEOS and Osara Health Partner to Enhance Cancer Care

FINEOS, the leading modern enterprise core software for the life, accident and health industry, has forged a partnership with Osara Health, a digital health platform founded by oncologists, to enhance the care experience for individuals dealing with cancer. The partnership will offer integration of additional services for cancer patients and caregivers to insurance carriers using the FINEOS Platform for group, voluntary, individual and absence. Osara Health’s Cancer Coach initiative has demonstrated significant ability to improve overall return-to-work rates by 73%, and average time to return to work by 16.5 weeks in a recent Australian study. Osara Health plans to replicate this study in the U.S. market over the coming months. The recently introduced Cancer Caregivers program provides services for caregivers, enabling them to sustain employment and maintain productivity.

COLLABORATION PARTNERSHIP

#institution

#virtual care

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 13,2023 TOP STORY

Coreline Soft to deploy AI lung cancer screening software in France

Coreline Soft has formalised its partnership with the radiology network imaGen to deploy its AI lung cancer screening solution in France. Its AVIEW LCS Plus software, which uses AI to detect and analyse cancerous lung nodules, emphysema, and calcium in the coronary artery, has recently been validated for routine clinical use at Imagerie Médicale des Deux Provinces (IM2P) and Imagerie Paris Centre (IPC), both member radiologist groups under imaGen. IM2P is a group of 62 radiologists practising at over 20 sites in the Côte d'Or and Jura regions, while IPC is a collective of 33 radiologists based in the French capital.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Oct 10,2023 TOP STORY

Virta Health Partners with PBM Navitus Health Solutions to Address Type 2 Diabetes and Obesity Epidemics

Virta Health and pharmacy benefits manager (PBM) Navitus Health Solutions are partnering to bring Virta’s reversal solutions for type 2 diabetes, prediabetes, and obesity to Navitus’ clients. Virta Health highlights in the press release that this announcement underscores the ongoing desire of employers and plan sponsors to address the challenges of metabolic disease within their covered populations, especially amid the rapid growth of GLP-1 medications both for diabetes and weight loss. The partnership addresses this trend. Patients with type 2 diabetes and prediabetes completing one year in Virta’s clinical trial experienced 12% and 13% weight loss, respectively. Virta’s provider-led, nutrition-based solutions will be offered through Navitus to maximize value for clients.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Oct 11,2023

Amwell Partners With Discovery Health in South Africa For Prescribing SilverCloud

Discovery Health, health insurance administrator providing administration and managed care services to more than 3.8 million individuals, has partnered with Amwell to introduce the first-ever digital therapeutic benefits funded by a health insurer in South Africa. As part of the organization’s robust mental healthcare program and benefits package, clinicians are now able to prescribe SilverCloud by Amwell, a clinically validated, evidence-based and affordable digital mental healthcare platform, to members.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Oct 10,2023 TOP STORY

Virta Health Partners with PBM Navitus Health Solutions to Address Type 2 Diabetes and Obesity Epidemics

Virta Health and pharmacy benefits manager (PBM) Navitus Health Solutions are partnering to bring Virta’s reversal solutions for type 2 diabetes, prediabetes, and obesity to Navitus’ clients. Virta Health highlights in the press release that this announcement underscores the ongoing desire of employers and plan sponsors to address the challenges of metabolic disease within their covered populations, especially amid the rapid growth of GLP-1 medications both for diabetes and weight loss. The partnership addresses this trend. Patients with type 2 diabetes and prediabetes completing one year in Virta’s clinical trial experienced 12% and 13% weight loss, respectively. Virta’s provider-led, nutrition-based solutions will be offered through Navitus to maximize value for clients.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Oct 06,2023

Teladoc Health Offers Clients Access to Musculoskeletal Health with Hinge Health

Teladoc Health, the global leader in whole person virtual care, has entered into a reseller partnership with Hinge Health to give Teladoc clients the opportunity to secure musculoskeletal (MSK) care and support from Hinge Health through their relationship with Teladoc Health. “The linkages between musculoskeletal pain and primary care, chronic conditions, and mental health are evident” said Kelly Bliss, Teladoc Health US Group Health President. “By bringing these additional capabilities to clients, this partnership allows both organizations to work together to more fully meet the needs of our clients' populations.” Dr. Jeff Krauss, Chief Medical Officer, Hinge Health said “Complementing Teladoc’s whole-person approach, our program offers a user-friendly experience, backed by a multidisciplinary human care team, that can be personalized to address pain throughout the body.”

COLLABORATION PARTNERSHIP

#institution

#virtual care

#mobile app

View Analyst & Ambassador Comments
Go to original news